Annotations
Pathway Ontology
classic metabolic pathway (PW:0000002)
The various, enzyme controlled, series of reactions allowing for the conversion of materials, energy availability and biodegradation of xenobiotics.|The definition was compiled based on a number of available defintions in various dictionaries.
Table Filters
- Lipids measured in liver metastasis from breast cancer - WP4627 (Mus musculus)
- 7-oxo-C and 7-beta-HC pathways - WP5064 (Homo sapiens)
- ABA biosynthesis - WP2626 (Solanum lycopersicum)
- ADHD and autism (ASD) pathways - WP5420 (Homo sapiens)
- ALA oxylipin metabolism - WP5136 (Homo sapiens)
- AMP-activated protein kinase signaling - WP1403 (Homo sapiens)
- AMPK signaling - WP3154 (Bos taurus)
- Abscisic acid biosynthesis - WP626 (Arabidopsis thaliana)
- Acetaminophen synthesis - WP2886 (Escherichia coli)
- Acetogenesis - WP5019 (Acetobacterium woodii)
- Acetylcholine synthesis - WP1034 (Bos taurus)
- Acetylcholine synthesis - WP175 (Mus musculus)
- Acetylcholine synthesis - WP264 (Caenorhabditis elegans)
- Acetylcholine synthesis - WP360 (Rattus norvegicus)
- Acetylcholine synthesis - WP476 (Danio rerio)
- Acetylcholine synthesis - WP528 (Homo sapiens)
- Acrylamide biotransformation and exposure biomarkers - WP4233 (Homo sapiens)
- Adverse outcome pathway for mitochondrial complex 1 (C1) inhibition - WP4914 (Homo sapiens)
- Aerobic glycerol catabolism - WP224 (Saccharomyces cerevisiae)
- Aerobic glycolysis - WP4629 (Homo sapiens)
- Aerobic glycolysis - augmented - WP4628 (Homo sapiens)
- Aflatoxin B1 metabolism - WP1217 (Equus caballus)
- Aflatoxin B1 metabolism - WP1262 (Mus musculus)
- Aflatoxin B1 metabolism - WP1300 (Rattus norvegicus)
- Aflatoxin B1 metabolism - WP3247 (Bos taurus)
- Aflatoxin B1 metabolism - WP699 (Homo sapiens)
- Aflatoxin B1 metabolism - WP925 (Pan troglodytes)
- Alanine and aspartate metabolism - WP106 (Homo sapiens)
- Alanine and aspartate metabolism - WP240 (Mus musculus)
- Alanine and aspartate metabolism - WP3262 (Bos taurus)
- Allantoin degradation - WP328 (Saccharomyces cerevisiae)
- Alternative pathway of fetal androgen synthesis - WP4524 (Homo sapiens)
- Amino acid conjugation - WP715 (Homo sapiens)
- Amino acid conjugation of benzoic acid - WP1008 (Bos taurus)
- Amino acid conjugation of benzoic acid - WP1252 (Mus musculus)
- Amino acid conjugation of benzoic acid - WP1287 (Rattus norvegicus)
- Amino acid conjugation of benzoic acid - WP1577 (Sus scrofa)
- Amino acid conjugation of benzoic acid - WP521 (Homo sapiens)
- Amino acid metabolism - WP3925 (Homo sapiens)
- Amino acid metabolism - WP662 (Mus musculus)
- Amino acid metabolism in triple-negative breast cancer cells - WP5213 (Homo sapiens)
- Amino acid metabolism pathway excerpt: histidine catabolism extension - WP4661 (Homo sapiens)
- Anaerobic respiration - WP575 (Saccharomyces cerevisiae)
- Arachidonate epoxygenase / epoxide hydrolase - WP1000 (Bos taurus)
- Arachidonate epoxygenase / epoxide hydrolase - WP1250 (Mus musculus)
- Arachidonate epoxygenase / epoxide hydrolase - WP678 (Homo sapiens)
- Arachidonic acid (AA, ARA) oxylipin metabolism - WP5155 (Homo sapiens)
- Arginine biosynthesis - WP275 (Saccharomyces cerevisiae)
- Arginine degradation - WP54 (Saccharomyces cerevisiae)
- Aripiprazole metabolic pathway - WP2640 (Homo sapiens)
- Arsenic metabolism and reactive oxygen species generation - WP5233 (Homo sapiens)
- Arylamine metabolism - WP1211 (Equus caballus)
- Arylamine metabolism - WP694 (Homo sapiens)
- Arylamine metabolism - WP993 (Bos taurus)
- Ascaroside biosynthesis - WP2224 (Caenorhabditis elegans)
- Ascorbate and aldarate metabolism - WP1622 (Mycobacterium tuberculosis)
- Asparagine biosynthesis - WP67 (Saccharomyces cerevisiae)
- Asparagine degradation - WP432 (Saccharomyces cerevisiae)
- Aspartate biosynthesis - WP1518 (Saccharomyces cerevisiae)
- AtMetExpress overview - WP3622 (Arabidopsis thaliana)
- Bacterial ceramide synthesis - WP5271 (Caulobacter vibrioides)
- Benzene metabolism - WP3891 (Homo sapiens)
- Benzo(a)pyrene metabolism - WP3263 (Bos taurus)
- Benzo(a)pyrene metabolism - WP696 (Homo sapiens)
- Beta-alanine biosynthesis - WP2207 (Oryza sativa)
- Beta-oxidation meta-pathway - WP372 (Rattus norvegicus)
- Beta-oxidation of unsaturated fatty acids - WP418 (Rattus norvegicus)
- Beta-oxidation of unsaturated fatty acids - WP471 (Caenorhabditis elegans)
- Bile acid synthesis and enterohepatic circulation - WP4389 (Homo sapiens)
- Biochemical pathways: part I - WP3604 (Homo sapiens)
- Biogenic amine synthesis - WP1118 (Canis familiaris)
- Biogenic amine synthesis - WP125 (Drosophila melanogaster)
- Biogenic amine synthesis - WP154 (Danio rerio)
- Biogenic amine synthesis - WP3168 (Bos taurus)
- Biogenic amine synthesis - WP522 (Mus musculus)
- Biogenic amine synthesis - WP550 (Homo sapiens)
- Biomarkers for pyrimidine metabolism disorders - WP4584 (Homo sapiens)
- Biomarkers for urea cycle disorders - WP4583 (Homo sapiens)
- Biosynthesis and regeneration of tetrahydrobiopterin and catabolism of phenylalanine - WP4156 (Homo sapiens)
- Biosynthesis and regulation of nematode bile acids - WP2293 (Caenorhabditis elegans)
- Biosynthesis and turnover of 1-deoxy-sphingoid bases - WP5179 (Homo sapiens)
- Biosynthesis of aldosterone and cortisol - WP508 (Rattus norvegicus)
- Biosynthesis of anthocyanins from phenylalanine in purple corn - WP5421 (Zea mays)
- Biosynthesis of gamma-aminobutyric acid (GABA) by polyamine oxidation - WP4232 (Arabidopsis thaliana)
- Biosynthesis of the three types of mycolic acids - WP4198 (Mycobacterium tuberculosis)
- Biotin metabolism - WP1631 (Mycobacterium tuberculosis)
- Biotin metabolism, including IMDs - WP5031 (Homo sapiens)
- Brassinolide biosynthetic pathway - WP2634 (Arabidopsis thaliana)
- Butyrate-induced histone acetylation - WP2366 (Homo sapiens)
- Butyrate-induced histone acetylation - WP3249 (Bos taurus)
- CBD synthetic pathway - WP5392 (Arabidopsis thaliana)
- Caffeine and theobromine metabolism - WP3633 (Homo sapiens)
- Calvin cycle - WP2860 (Populus trichocarpa)
- Cannabinoid receptor signaling - WP3869 (Homo sapiens)
- Carbon assimilation C4 pathway - WP1493 (Zea mays)
- Carbon monoxide dehydrogenase pathway - WP280 (Saccharomyces cerevisiae)
- Cardiolipin biosynthesis - WP2208 (Oryza sativa)
- Carnosine metabolism of glial cells - WP5313 (Homo sapiens)
- Carotenoid biosynthesis - WP2205 (Zea mays)
- Catecholamine synthesis - WP513 (Rattus norvegicus)
- Cellular proteostasis - WP4918 (Homo sapiens)
- Central carbon metabolism - WP3583 (Escherichia coli)
- Cerebral organic acidurias, including diseases - WP4519 (Homo sapiens)
- Chlorophyll b degradation - WP2230 (Arabidopsis thaliana)
- Chloroplast electron transport chain - WP2861 (Populus trichocarpa)
- Cholesterol biosynthesis - WP103 (Mus musculus)
- Cholesterol biosynthesis - WP1070 (Bos taurus)
- Cholesterol biosynthesis - WP1186 (Canis familiaris)
- Cholesterol biosynthesis - WP132 (Saccharomyces cerevisiae)
- Cholesterol biosynthesis - WP1387 (Danio rerio)
- Cholesterol biosynthesis - WP833 (Gallus gallus)
- Cholesterol biosynthesis - WP952 (Pan troglodytes)
- Cholesterol biosynthesis pathway - WP197 (Homo sapiens)
- Cholesterol biosynthesis pathway in hepatocytes - WP5329 (Homo sapiens)
- Cholesterol biosynthesis with skeletal dysplasias - WP4804 (Homo sapiens)
- Cholesterol metabolism - WP5304 (Homo sapiens)
- Cholesterol metabolism - WP632 (Rattus norvegicus)
- Cholesterol metabolism with Bloch and Kandutsch-Russell pathways - WP4346 (Mus musculus)
- Cholesterol metabolism with Bloch and Kandutsch-Russell pathways - WP4718 (Homo sapiens)
- Cholesterol synthesis disorders - WP5193 (Homo sapiens)
- Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism - WP4523 (Homo sapiens)
- Cocaine metabolism - WP2826 (Homo sapiens)
- Codeine and morphine metabolism - WP1604 (Homo sapiens)
- Codeine and morphine metabolism - WP3270 (Bos taurus)
- Colanic acid building blocks biosynthesis - WP121 (Saccharomyces cerevisiae)
- Colchicine metabolic pathway - WP2536 (Homo sapiens)
- Conversion of angiotensinogen to angiotensin II - WP4818 (Homo sapiens)
- Cori cycle - WP1946 (Homo sapiens)
- Cori cycle - WP3114 (Bos taurus)
- Creatine pathway - WP5190 (Homo sapiens)
- Cysteine and methionine catabolism - WP4504 (Homo sapiens)
- Cysteine biosynthesis from homoserine - WP256 (Saccharomyces cerevisiae)
- D-arginine and D-ornithine metabolism - WP1642 (Mycobacterium tuberculosis)
- DON mycotoxin biosynthesis - WP2258 (Gibberella zeae)
- De novo NAD biosynthesis - WP541 (Saccharomyces cerevisiae)
- De novo biosynthesis of purine nucleotides - WP203 (Saccharomyces cerevisiae)
- De novo biosynthesis of pyrimidine deoxyribonucleotides - WP36 (Saccharomyces cerevisiae)
- De novo biosynthesis of pyrimidine ribonucleotides - WP92 (Saccharomyces cerevisiae)
- Degradation pathway of sphingolipids, including diseases - WP4153 (Homo sapiens)
- Dengue-2 interactions with complement and coagulation cascades - WP3896 (Homo sapiens)
- Deoxyribose phosphate metabolism - WP228 (Saccharomyces cerevisiae)
- Diclofenac metabolic pathway - WP2491 (Homo sapiens)
- Diet-dependent trimethylamine/trimethylamine N-oxide metabolism - WP5219 (Homo sapiens)
- Disorders in ketolysis - WP5195 (Homo sapiens)
- Disorders in ketone body synthesis - WP5175 (Homo sapiens)
- Disorders of bile acid synthesis and biliary transport - WP5176 (Homo sapiens)
- Disorders of fructose metabolism - WP5178 (Homo sapiens)
- Disorders of galactose metabolism - WP5173 (Homo sapiens)
- Docosahexaenoic acid oxylipin metabolism - WP5154 (Homo sapiens)
- Dopamine metabolism - WP2436 (Homo sapiens)
- Dopamine metabolism - WP3155 (Bos taurus)
- EPO receptor signaling - WP581 (Homo sapiens)
- Ebstein-Barr virus LMP1 signaling - WP262 (Homo sapiens)
- Effect of L-carnitine on metabolism - WP3992 (Danio rerio)
- Eicosanoid lipid synthesis map - WP4335 (Mus musculus)
- Eicosanoid metabolism via cyclooxygenases (COX) - WP4347 (Mus musculus)
- Eicosanoid metabolism via cyclooxygenases (COX) - WP4719 (Homo sapiens)
- Eicosanoid metabolism via cytochrome P450 monooxygenases - WP4349 (Mus musculus)
- Eicosanoid metabolism via cytochrome P450 monooxygenases pathway - WP4720 (Homo sapiens)
- Eicosanoid metabolism via lipooxygenases (LOX) - WP4721 (Homo sapiens)
- Eicosanoid metabolism via lipoxygenases (LOX) - WP4348 (Mus musculus)
- Eicosanoid synthesis - WP1090 (Canis familiaris)
- Eicosanoid synthesis - WP1318 (Danio rerio)
- Eicosanoid synthesis - WP167 (Homo sapiens)
- Eicosanoid synthesis - WP318 (Mus musculus)
- Eicosanoid synthesis - WP854 (Pan troglodytes)
- Eicosanoid synthesis - WP972 (Bos taurus)
- Electron transport chain - WP1002 (Bos taurus)
- Electron transport chain - WP1119 (Canis familiaris)
- Electron transport chain - WP1339 (Danio rerio)
- Electron transport chain - WP295 (Mus musculus)
- Electron transport chain: OXPHOS system in mitochondria - WP111 (Homo sapiens)
- Elongation of (very) long chain fatty acids - WP4491 (Mus musculus)
- Energy metabolism - WP1541 (Homo sapiens)
- Enterocyte cholesterol metabolism - WP5333 (Homo sapiens)
- ErbB signaling pathway - WP673 (Homo sapiens)
- Ergosterol biosynthesis - WP5354 (Saccharomyces cerevisiae)
- Escherichia coli K-12 peripherome - WP2472 (Escherichia coli)
- Estrogen metabolism - WP1053 (Bos taurus)
- Estrogen metabolism - WP1264 (Mus musculus)
- Estrogen metabolism - WP1302 (Rattus norvegicus)
- Estrogen metabolism - WP5276 (Homo sapiens)
- Estrogen metabolism - WP697 (Homo sapiens)
- Ethanol metabolism resulting in production of ROS by CYP2E1 - WP4265 (Mus musculus)
- Ether lipid biosynthesis - WP5275 (Homo sapiens)
- Evolocumab mechanism to reduce LDL cholesterol - WP3408 (Homo sapiens)
- Farnesyl to CoQ10 metabolism - WP5274 (Homo sapiens)
- Fatty acid beta-oxidation - WP1269 (Mus musculus)
- Fatty acid beta-oxidation - WP143 (Homo sapiens)
- Fatty acid beta-oxidation 1 - WP126 (Caenorhabditis elegans)
- Fatty acid beta-oxidation 1 - WP39 (Drosophila melanogaster)
- Fatty acid beta-oxidation 2 - WP148 (Caenorhabditis elegans)
- Fatty acid beta-oxidation 3 - WP25 (Drosophila melanogaster)
- Fatty acid beta-oxidation 3 - WP499 (Caenorhabditis elegans)
- Fatty acid beta-oxidation meta-pathway - WP209 (Caenorhabditis elegans)
- Fatty acid biosynthesis - WP1020 (Bos taurus)
- Fatty acid biosynthesis - WP336 (Mus musculus)
- Fatty acid biosynthesis - WP357 (Homo sapiens)
- Fatty acid biosynthesis - WP38 (Caenorhabditis elegans)
- Fatty acid biosynthesis - WP504 (Rattus norvegicus)
- Fatty acid biosynthesis - WP568 (Drosophila melanogaster)
- Fatty acid biosynthesis, initial steps - WP137 (Saccharomyces cerevisiae)
- Fatty acid elongation, saturated - WP380 (Saccharomyces cerevisiae)
- Fatty acid elongation, unsaturated - WP16 (Saccharomyces cerevisiae)
- Fatty acid omega-oxidation - WP133 (Rattus norvegicus)
- Fatty acid omega-oxidation - WP206 (Homo sapiens)
- Fatty acid omega-oxidation - WP33 (Mus musculus)
- Fatty acid omega-oxidation - WP852 (Pan troglodytes)
- Fatty acid omega-oxidation - WP970 (Bos taurus)
- Fatty acid oxidation - WP2318 (Mus musculus)
- Fatty acid oxidation - WP91 (Saccharomyces cerevisiae)
- Fatty acids and lipoproteins transport in hepatocytes - WP5323 (Homo sapiens)
- Felbamate metabolism - WP2816 (Homo sapiens)
- Female steroid hormones in cardiomyocyte energy metabolism - WP5318 (Homo sapiens)
- Ferroptosis - WP4313 (Homo sapiens)
- Flavan-3-ol metabolic pathway - WP4238 (Homo sapiens)
- Flavonoid biosynthesis - WP1538 (Arabidopsis thaliana)
- Flavonoid pathway - WP3620 (Arabidopsis thaliana)
- Fluoroacetic acid toxicity - WP4966 (Homo sapiens)
- Folate biosynthesis - WP2360 (Bacillus subtilis)
- Fructose and mannose metabolism - WP1652 (Mycobacterium tuberculosis)
- Fructose metabolism in proximal tubules - WP3894 (Rattus norvegicus)
- GABA metabolism (aka GHB) - WP4157 (Homo sapiens)
- GABA receptor signaling - WP4159 (Homo sapiens)
- GLP-1 from intestine and pancreas and role in glucose homeostasis - WP5452 (Homo sapiens)
- GLP-1 in pancreatic islet cells - WP5447 (Homo sapiens)
- Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases - WP4518 (Homo sapiens)
- Ganglio series sphingolipid metabolism - WP5299 (Homo sapiens)
- Ganglio sphingolipid metabolism - WP1423 (Homo sapiens)
- Ganglio sphingolipid metabolism - WP3219 (Bos taurus)
- Geranylgeranyldiphosphate biosynthesis II (plastidic) - WP2211 (Oryza sativa)
- Gibberellin A12 biosynthesis - WP2628 (Solanum lycopersicum)
- Globo series sphingolipid metabolism - WP5305 (Mus musculus)
- Globo sphingolipid metabolism - WP3278 (Bos taurus)
- Glucocorticoid biosynthesis - WP5280 (Homo sapiens)
- Glucocorticoid metabolism - WP305 (Rattus norvegicus)
- Gluconeogenesis - WP2630 (Solanum lycopersicum)
- Glucose metabolism in triple-negative breast cancer cells - WP5211 (Homo sapiens)
- Glucose-1-phosphate metabolism - WP260 (Saccharomyces cerevisiae)
- Glucosinolate biosynthesis (from aromatic amino acid) - WP4598 (Arabidopsis thaliana)
- Glucosinolate biosynthesis from branched-chain amino acid - WP4599 (Arabidopsis thaliana)
- Glucosinolate biosynthesis from methionine - WP4597 (Arabidopsis thaliana)
- Glutamate biosynthesis - WP77 (Saccharomyces cerevisiae)
- Glutamate biosynthesis superpathway - WP191 (Saccharomyces cerevisiae)
- Glutamate degradation I - WP556 (Saccharomyces cerevisiae)
- Glutamate degradation III - WP503 (Saccharomyces cerevisiae)
- Glutamate degradation VII - WP559 (Saccharomyces cerevisiae)
- Glutamate degradation VIII - WP99 (Saccharomyces cerevisiae)
- Glutathione and one-carbon metabolism - WP730 (Mus musculus)
- Glutathione biosynthesis - WP196 (Saccharomyces cerevisiae)
- Glutathione metabolism - WP100 (Homo sapiens)
- Glutathione metabolism - WP164 (Mus musculus)
- Glutathione metabolism - WP3207 (Bos taurus)
- Glutathione metabolism - WP469 (Rattus norvegicus)
- Glycerol teichoic acid biosynthesis - WP563 (Saccharomyces cerevisiae)
- Glycerolipids and glycerophospholipids - WP4345 (Mus musculus)
- Glycerolipids and glycerophospholipids - WP4722 (Homo sapiens)
- Glycerolipids and glycerophospholipids - WP5296 (Mus musculus)
- Glycerophospholipid biosynthetic pathway - WP2533 (Homo sapiens)
- Glycerophospholipid biosynthetic pathway - WP3198 (Bos taurus)
- Glycine biosynthesis - WP261 (Saccharomyces cerevisiae)
- Glycine degradation - WP345 (Saccharomyces cerevisiae)
- Glycine metabolism - WP1495 (Homo sapiens)
- Glycine metabolism - WP3142 (Bos taurus)
- Glycine metabolism, including IMDs - WP5028 (Homo sapiens)
- Glycogen catabolism - WP478 (Saccharomyces cerevisiae)
- Glycogen metabolism - WP1073 (Bos taurus)
- Glycogen metabolism - WP1189 (Canis familiaris)
- Glycogen metabolism - WP1388 (Danio rerio)
- Glycogen metabolism - WP160 (Rattus norvegicus)
- Glycogen metabolism - WP317 (Mus musculus)
- Glycogen metabolism - WP436 (Caenorhabditis elegans)
- Glycogen metabolism - WP835 (Gallus gallus)
- Glycogen metabolism - WP955 (Pan troglodytes)
- Glycogen synthesis and degradation - WP500 (Homo sapiens)
- Glycolysis - WP253 (Saccharomyces cerevisiae)
- Glycolysis - WP2621 (Arabidopsis thaliana)
- Glycolysis - WP2862 (Populus trichocarpa)
- Glycolysis and Gluconeogenesis - WP96 (Caenorhabditis elegans)
- Glycolysis and gluconeogenesis - WP1027 (Bos taurus)
- Glycolysis and gluconeogenesis - WP1356 (Danio rerio)
- Glycolysis and gluconeogenesis - WP1567 (Mycobacterium tuberculosis)
- Glycolysis and gluconeogenesis - WP157 (Mus musculus)
- Glycolysis and gluconeogenesis - WP515 (Saccharomyces cerevisiae)
- Glycolysis and gluconeogenesis - WP534 (Homo sapiens)
- Glycolysis in senescence - WP5049 (Homo sapiens)
- Glycosaminoglycan degradation - WP4815 (Homo sapiens)
- Glycosaminoglycan synthesis in fibroblasts - WP5395 (Homo sapiens)
- Glycosphingolipid metabolism - WP5292 (Homo sapiens)
- Glycosylation and related congenital defects - WP4521 (Homo sapiens)
- Glyoxylate cycle - WP2566 (Mycobacterium tuberculosis)
- Glyoxylate metabolism - WP5166 (Homo sapiens)
- Glyoxylate, anapleurotic and succinyl CoA (GAS) pathway - WP2638 (Mycobacterium tuberculosis)
- Gut-liver indole metabolism - WP3627 (Homo sapiens)
- HIF1A and PPARG regulation of glycolysis - WP2456 (Homo sapiens)
- Heroin metabolism - WP2645 (Homo sapiens)
- Hexoses metabolism in proximal tubules - WP3916 (Rattus norvegicus)
- Histidine metabolism - WP1581 (Mycobacterium tuberculosis)
- Histidine, purine, and pyrimidine superpathway - WP416 (Saccharomyces cerevisiae)
- Homocysteine and cysteine interconversion - WP128 (Saccharomyces cerevisiae)
- IDO metabolic pathway - WP5414 (Homo sapiens)
- IL-1 signaling pathway - WP195 (Homo sapiens)
- IL-18 signaling pathway - WP4754 (Homo sapiens)
- Induction of autophagy and toll-like receptor signaling pathways by graphene oxide - WP5336 (Homo sapiens)
- Iron-sulfur cluster biogenesis - WP5152 (Homo sapiens)
- Isoglobo series sphingolipids - WP5311 (Homo sapiens)
- Isoleucine and valine biosynthesis - WP359 (Saccharomyces cerevisiae)
- Isoleucine degradation - WP178 (Saccharomyces cerevisiae)
- Isoleucine, leucine, and valine biosynthesis - WP198 (Saccharomyces cerevisiae)
- Kennedy pathway - WP1771 (Mus musculus)
- Kennedy pathway from sphingolipids - WP3933 (Homo sapiens)
- Ketogenesis and ketolysis - WP4742 (Homo sapiens)
- Ketone bodies synthesis and degradation - WP1015 (Bos taurus)
- Ketone bodies synthesis and degradation - WP1134 (Canis familiaris)
- Ketone bodies synthesis and degradation - WP427 (Caenorhabditis elegans)
- Ketone bodies synthesis and degradation - WP784 (Gallus gallus)
- Ketone bodies synthesis and degradation - WP898 (Pan troglodytes)
- Kinin-Kallikrein pathway - WP5089 (Homo sapiens)
- Krebs cycle - WP2863 (Populus trichocarpa)
- Krebs cycle disorders - WP4236 (Homo sapiens)
- Kynurenine pathway and links to cell senescence - WP5044 (Homo sapiens)
- Lac-Phe pathway - WP5239 (Homo sapiens)
- Lac-Phe pathway - WP5240 (Mus musculus)
- Lactate shuttle in glial cells - WP5314 (Homo sapiens)
- Lacto series sphingolipid metabolism - WP5303 (Homo sapiens)
- Lactose degradation and galactose metabolism - WP546 (Saccharomyces cerevisiae)
- Leucine biosynthesis - WP180 (Saccharomyces cerevisiae)
- Leucine degradation - WP354 (Saccharomyces cerevisiae)
- Leucine, isoleucine and valine metabolism - WP4686 (Homo sapiens)
- Leukotriene metabolic pathway - WP5171 (Homo sapiens)
- Lidocaine metabolism - WP2646 (Homo sapiens)
- Lidocaine metabolism - WP3254 (Bos taurus)
- Linoleate biosynthesis - WP1996 (Arabidopsis thaliana)
- Linoleic acid metabolism affected by SARS-CoV-2 - WP4853 (Homo sapiens)
- Linoleic acid oxylipin metabolism - WP5137 (Homo sapiens)
- Lipases biosynthesis - WP71 (Saccharomyces cerevisiae)
- Lipid droplet metabolism - WP3901 (Rattus norvegicus)
- Lipid metabolism in senescent cells - WP5149 (Homo sapiens)
- Lipid metabolism pathway - WP3965 (Homo sapiens)
- Lipid particles composition - WP3601 (Homo sapiens)
- Lipid remodeling - WP5290 (Anopheles gambiae)
- Lipoic acid metabolism - WP1667 (Mycobacterium tuberculosis)
- Lycopene biosynthesis - WP2204 (Zea mays)
- Major receptors targeted by epinephrine and norepinephrine - WP4589 (Homo sapiens)
- Malate-aspartate shuttle - WP4315 (Homo sapiens)
- Male steroid hormones in cardiomyocyte energy metabolism - WP5320 (Homo sapiens)
- Metabolic pathway of LDL, HDL and TG, including diseases - WP4522 (Homo sapiens)
- Metabolic pathways of fibroblasts - WP5312 (Homo sapiens)
- Metabolic reprogramming in colon cancer - WP4290 (Homo sapiens)
- Metabolic reprogramming in pancreatic cancer - WP5220 (Homo sapiens)
- Metabolism of T-2 toxin and HT-2 toxin - WP5425 (Triticum aestivum)
- Metabolism of alpha-linolenic acid - WP4586 (Homo sapiens)
- Metabolism of dichloroethylene by CYP450 - WP3666 (Homo sapiens)
- Metabolism of sphingolipids in ER and Golgi apparatus - WP4142 (Homo sapiens)
- Metabolism of tetrahydrocannabinol (THC) - WP4174 (Homo sapiens)
- Metabolism overview - WP3602 (Homo sapiens)
- Metapathway UDP-glucuronosyltransferases - WP1431 (Caenorhabditis elegans)
- Metapathway biotransformation - WP1212 (Equus caballus)
- Methionine de novo and salvage pathway - WP3580 (Homo sapiens)
- Methionine metabolism leading to sulfur amino acids and related disorders - WP4292 (Homo sapiens)
- Methylation pathways - WP704 (Homo sapiens)
- Methylerythritol phosphate pathway - WP2212 (Oryza sativa)
- Mevalonate arm of cholesterol biosynthesis pathway - WP4190 (Homo sapiens)
- Mevalonate arm of cholesterol biosynthesis pathway with inhibitors - WP4189 (Homo sapiens)
- Mevalonate pathway - WP3963 (Homo sapiens)
- Mineralocorticoid biosynthesis - WP5279 (Homo sapiens)
- Mitochondrial beta-oxidation - WP5241 (Homo sapiens)
- Mitochondrial complex I assembly model OXPHOS system - WP4324 (Homo sapiens)
- Mitochondrial complex I inhibition leading to chemical-induced Fanconi syndrome - WP4944 (Homo sapiens)
- Mitochondrial complex I inhibition leading to parkinsonian motor deficits - WP4945 (Homo sapiens)
- Mitochondrial complex II assembly - WP4920 (Homo sapiens)
- Mitochondrial complex III assembly - WP4921 (Homo sapiens)
- Mitochondrial complex IV assembly - WP4922 (Homo sapiens)
- Mitochondrial fatty acid oxidation disorders - WP5123 (Homo sapiens)
- Mitochondrial fatty acid synthesis pathway - WP4317 (Homo sapiens)
- Mitochondrial long chain fatty acid beta-oxidation - WP368 (Homo sapiens)
- Mitochondrial long chain fatty acid beta-oxidation - WP401 (Mus musculus)
- Mitochondrial long chain fatty acid beta-oxidation - WP406 (Drosophila melanogaster)
- Mitochondrial long chain fatty acid beta-oxidation - WP448 (Caenorhabditis elegans)
- Mitochondrial long chain fatty acid beta-oxidation - WP498 (Danio rerio)
- Mitochondrial long chain fatty acid beta-oxidation - WP763 (Gallus gallus)
- Mitochondrial long chain fatty acid beta-oxidation - WP989 (Bos taurus)
- Molybdenum cofactor (Moco) biosynthesis - WP4507 (Homo sapiens)
- Momilactone biosynthesis - WP2209 (Oryza sativa)
- Monoterpene biosynthesis pathway in mint - WP4701 (Vitis vinifera)
- N-glycan biosynthesis - WP5153 (Homo sapiens)
- N-glycan biosynthesis - WP5196 (Ovis aries)
- NAD biosynthesis - WP84 (Saccharomyces cerevisiae)
- NAD biosynthesis I from aspartate - WP2484 (Escherichia coli)
- NAD biosynthesis II (from tryptophan) - WP2485 (Homo sapiens)
- NAD biosynthesis II from tryptophan - WP3228 (Bos taurus)
- NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence - WP5046 (Homo sapiens)
- NAD metabolism, sirtuins and aging - WP3630 (Homo sapiens)
- NAD salvage pathway - WP171 (Saccharomyces cerevisiae)
- NAD salvage pathway I - WP2486 (Escherichia coli)
- NAD salvage pathway II - WP2487 (Escherichia coli)
- NAD salvage pathway III - WP2488 (Escherichia coli)
- NAD+ biosynthetic pathways - WP3645 (Homo sapiens)
- NAD+ metabolism - WP3644 (Homo sapiens)
- Nanomaterial-induced inflammasome activation - WP3890 (Homo sapiens)
- Neolacto series sphingolipid metabolism - WP5302 (Homo sapiens)
- Neurotransmitter disorders - WP4220 (Homo sapiens)
- Nicotine metabolism in liver cells - WP1600 (Homo sapiens)
- Non-classical role of vitamin D - WP5133 (Homo sapiens)
- Nuclear receptors in lipid metabolism and toxicity - WP1099 (Canis familiaris)
- Nuclear receptors in lipid metabolism and toxicity - WP1326 (Danio rerio)
- Nuclear receptors in lipid metabolism and toxicity - WP139 (Rattus norvegicus)
- Nuclear receptors in lipid metabolism and toxicity - WP299 (Homo sapiens)
- Nuclear receptors in lipid metabolism and toxicity - WP431 (Mus musculus)
- Nuclear receptors in lipid metabolism and toxicity - WP755 (Gallus gallus)
- Nuclear receptors in lipid metabolism and toxicity - WP863 (Pan troglodytes)
- Nuclear receptors in lipid metabolism and toxicity - WP981 (Bos taurus)
- Nucleotide metabolism - WP146 (Rattus norvegicus)
- Nucleotide metabolism - WP321 (Saccharomyces cerevisiae)
- Nucleotide metabolism - WP3211 (Bos taurus)
- Octadecanoid formation from linoleic acid - WP5324 (Homo sapiens)
- Octane oxidation - WP552 (Saccharomyces cerevisiae)
- Omega-3 / omega-6 fatty acid synthesis - WP4350 (Mus musculus)
- Omega-3 / omega-6 fatty acid synthesis - WP4723 (Homo sapiens)
- Omega-6-fatty acids in senescence - WP5424 (Homo sapiens)
- Omega-9 fatty acid synthesis - WP4351 (Mus musculus)
- Omega-9 fatty acid synthesis - WP4724 (Homo sapiens)
- One-carbon metabolism - WP1355 (Danio rerio)
- Ophthalmate biosynthesis in hepatocytes - WP4487 (Homo sapiens)
- Orexin receptor pathway - WP5094 (Homo sapiens)
- Oryzalexin S biosynthesis - WP2210 (Oryza sativa)
- Osteoarthritic chondrocyte hypertrophy - WP5373 (Homo sapiens)
- Oxidation by cytochrome P450 - WP1077 (Bos taurus)
- Oxidation by cytochrome P450 - WP43 (Homo sapiens)
- Oxidative phosphorylation - WP1248 (Mus musculus)
- Oxidative phosphorylation - WP1283 (Rattus norvegicus)
- Oxidative phosphorylation - WP1335 (Danio rerio)
- Oxidative phosphorylation - WP623 (Homo sapiens)
- Oxidative phosphorylation - WP994 (Bos taurus)
- Oxidative stress and redox pathway - WP4466 (Mus musculus)
- Oxysterols derived from cholesterol - WP4545 (Homo sapiens)
- P-cymene degradation - WP181 (Saccharomyces cerevisiae)
- PCSK9-mediated LDL receptor degradation - WP2846 (Homo sapiens)
- PGK1, PKM2, KHKC/KHKA acting as protein kinases - WP5433 (Homo sapiens)
- Pantothenate and coenzyme A biosynthesis - WP462 (Saccharomyces cerevisiae)
- Pentose pathway, non-oxidative branch - WP379 (Saccharomyces cerevisiae)
- Pentose phosphate metabolism - WP134 (Homo sapiens)
- Pentose phosphate pathway - WP1028 (Bos taurus)
- Pentose phosphate pathway - WP1231 (Anopheles gambiae)
- Pentose phosphate pathway - WP282 (Rattus norvegicus)
- Pentose phosphate pathway - WP312 (Caenorhabditis elegans)
- Pentose phosphate pathway - WP369 (Saccharomyces cerevisiae)
- Pentose phosphate pathway - WP63 (Mus musculus)
- Pentose phosphate pathway 2 - WP670 (Saccharomyces cerevisiae)
- Pentose phosphate pathway in senescent cells - WP5043 (Homo sapiens)
- Peptidoglycan cytoplasmic synthesis and recycling pathways - WP5060 (Escherichia coli)
- Peroxisomal beta-oxidation of tetracosanoyl-CoA - WP1941 (Homo sapiens)
- Peroxisomal beta-oxidation of tetracosanoyl-CoA - WP3146 (Bos taurus)
- Phenylalanine biosynthesis - WP194 (Saccharomyces cerevisiae)
- Phenylalanine degradation - WP573 (Saccharomyces cerevisiae)
- Phenylalanine, tyrosine, and tryptophan biosynthesis - WP27 (Saccharomyces cerevisiae)
- Phosphatidic acid and phospholipid biosynthesis - WP472 (Saccharomyces cerevisiae)
- Phosphatidyl inositol phosphate pathway - WP5411 (Homo sapiens)
- Phosphatidylcholine catabolism - WP4195 (Homo sapiens)
- Phosphoinositides metabolism - WP4971 (Homo sapiens)
- Phospholipid biosynthesis - WP9 (Saccharomyces cerevisiae)
- Phospholipid biosynthesis - WP5201 (Saccharomyces cerevisiae)
- Photosynthetic carbon reduction - WP1461 (Arabidopsis thaliana)
- Poly(glycerol phosphate) wall teichoic acid biosynthesis - WP4162 (Saccharomyces cerevisiae)
- Polyamine biosynthesis - WP290 (Saccharomyces cerevisiae)
- Primary carbon metabolism - WP2859 (Populus trichocarpa)
- Proline and hydroxyproline pathways - WP5026 (Homo sapiens)
- Prostaglandin and leukotriene metabolism in senescence - WP5122 (Homo sapiens)
- Prostaglandin and leukotriene metabolism in senescence - WP5321 (Homo sapiens)
- Prostaglandin synthesis and regulation - WP303 (Rattus norvegicus)
- Prostaglandin synthesis and regulation - WP374 (Mus musculus)
- Prostaglandin synthesis and regulation - WP98 (Homo sapiens)
- Prostaglandin synthesis and regulation - WP995 (Bos taurus)
- Proteoglycan biosynthesis - WP4784 (Homo sapiens)
- PtdIns(4,5)P2 in cytokinesis pathway - WP5199 (Homo sapiens)
- Purine fermentation - WP463 (Saccharomyces cerevisiae)
- Purine metabolism - WP2185 (Mus musculus)
- Purine metabolism - WP4792 (Homo sapiens)
- Purine metabolism and related disorders - WP4224 (Homo sapiens)
- Pyrimidine metabolism - WP4022 (Homo sapiens)
- Pyrimidine metabolism and related diseases - WP4225 (Homo sapiens)
- Pyrimidine ribonucleotide salvage pathways - WP95 (Saccharomyces cerevisiae)
- Pyruvate dehydrogenase pathway - WP214 (Saccharomyces cerevisiae)
- Relationship between inflammation, COX-2 and EGFR - WP4483 (Homo sapiens)
- Renin-angiotensin-aldosterone system (RAAS) - WP4756 (Homo sapiens)
- Representative anthocyanin biosynthetic pathway - WP5391 (Arabidopsis thaliana)
- Response regulator aspartate phosphatase interactions - WP1466 (Bacillus subtilis)
- Retinol metabolism - WP1259 (Mus musculus)
- Retinol metabolism - WP1297 (Rattus norvegicus)
- Retinol metabolism - WP5188 (Homo sapiens)
- Retinol metabolism - WP805 (Gallus gallus)
- Riboflavin and CoQ disorders - WP5037 (Homo sapiens)
- Riboflavin, FMN, and FAD biosynthesis - WP381 (Saccharomyces cerevisiae)
- Ribose and deoxyribose phosphate metabolism - WP220 (Saccharomyces cerevisiae)
- Role of carnosine in muscle contraction - WP4486 (Homo sapiens)
- Role of lipid metabolism - WP2915 (Caenorhabditis elegans)
- RuMP cycle, oxidative branch of the pentose phosphate pathway and formaldehyde assimilation - WP332 (Saccharomyces cerevisiae)
- SCFA and skeletal muscle substrate metabolism - WP4030 (Homo sapiens)
- SK UDPglcnac - WP3641 (Escherichia coli)
- SREBF and miR33 in cholesterol and lipid homeostasis - WP2011 (Homo sapiens)
- SREBP signaling - WP3194 (Bos taurus)
- Sebaleic acid formation and metabolism - WP5315 (Homo sapiens)
- Selenium metabolism / selenoproteins - WP108 (Mus musculus)
- Selenium metabolism and selenoproteins - WP28 (Homo sapiens)
- Selenium metabolism selenoproteins - WP1293 (Rattus norvegicus)
- Selenium metabolism selenoproteins - WP1358 (Danio rerio)
- Selenium micronutrient network - WP1272 (Mus musculus)
- Selenium micronutrient network - WP15 (Homo sapiens)
- Selenium micronutrient network - WP3257 (Bos taurus)
- Selenium micronutrient network - WP1310 (Rattus norvegicus)
- Serine and glycine biosynthesis - WP218 (Saccharomyces cerevisiae)
- Serine biosynthesis - WP459 (Saccharomyces cerevisiae)
- Serine metabolism - WP4688 (Homo sapiens)
- Serine-isocitrate lyase pathway - WP390 (Saccharomyces cerevisiae)
- Serotonin reuptake inhibitor response - WP5237 (Daphnia magna)
- Sphingolipid metabolism - WP3232 (Bos taurus)
- Sphingolipid metabolism - WP370 (Saccharomyces cerevisiae)
- Sphingolipid metabolism (integrated pathway) - WP4690 (Mus musculus)
- Sphingolipid metabolism in senescence - WP5121 (Homo sapiens)
- Sphingolipid metabolism overview - WP4344 (Mus musculus)
- Sphingolipid metabolism overview - WP4725 (Homo sapiens)
- Sphingolipid metabolism: integrated pathway - WP4726 (Homo sapiens)
- Sphingolipid pathway - WP1422 (Homo sapiens)
- Starch and cellulose biosynthesis - WP257 (Saccharomyces cerevisiae)
- Starch metabolism - WP2622 (Arabidopsis thaliana)
- Steroid biosynthesis - WP1024 (Bos taurus)
- Steroid biosynthesis - WP496 (Homo sapiens)
- Steroid biosynthesis - WP55 (Mus musculus)
- Steroid biosynthesis - WP66 (Rattus norvegicus)
- Steroid hormone precursor biosynthesis - WP5277 (Homo sapiens)
- Sterol regulatory element-binding proteins (SREBP) signaling - WP1982 (Homo sapiens)
- Sucrose biosynthesis - WP14 (Saccharomyces cerevisiae)
- Sucrose metabolism - WP2623 (Arabidopsis thaliana)
- Sulfatase and aromatase pathway - WP5368 (Homo sapiens)
- Sulfate assimilation and copper detoxification - WP4173 (Saccharomyces cerevisiae)
- Sulfate assimilation pathway II - WP579 (Saccharomyces cerevisiae)
- Sulfide oxidation pathway - WP2235 (Caenorhabditis elegans)
- Sulfur amino acid biosynthesis - WP7 (Saccharomyces cerevisiae)
- Sulfur degradation - WP440 (Saccharomyces cerevisiae)
- Sulindac metabolic pathway - WP2541 (Rattus norvegicus)
- Sulindac metabolic pathway - WP2542 (Homo sapiens)
- Sulindac metabolic pathway - WP3150 (Bos taurus)
- Superpathway of pyridoxal 5'-phosphate biosynthesis and salvage - WP2631 (Solanum lycopersicum)
- Synthesis and degradation of ketone bodies - WP101 (Drosophila melanogaster)
- Synthesis and degradation of ketone bodies - WP349 (Rattus norvegicus)
- Synthesis and degradation of ketone bodies - WP543 (Mus musculus)
- Synthesis of ceramides and 1-deoxyceramides - WP5194 (Homo sapiens)
- TCA cycle - WP1227 (Anopheles gambiae)
- TCA cycle - WP19 (Danio rerio)
- TCA cycle - WP2563 (Mycobacterium tuberculosis)
- TCA cycle - WP347 (Rattus norvegicus)
- TCA cycle - WP434 (Mus musculus)
- TCA cycle - WP490 (Saccharomyces cerevisiae)
- TCA cycle - WP999 (Bos taurus)
- TCA cycle (Krebs cycle) - WP2624 (Arabidopsis thaliana)
- TCA cycle (aka Krebs or citric acid cycle) - WP78 (Homo sapiens)
- TCA cycle (plant) - WP3009 (Oryza sativa)
- TCA cycle - detailed - WP296 (Saccharomyces cerevisiae)
- TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) - WP2453 (Homo sapiens)
- TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) - WP3149 (Bos taurus)
- TCA cycle in senescence - WP5050 (Homo sapiens)
- TCA cycle nutrient use and invasiveness of ovarian cancer - WP2868 (Homo sapiens)
- TCA cycle nutrient use and invasiveness of ovarian cancer - WP3252 (Bos taurus)
- Tamoxifen metabolism - WP691 (Homo sapiens)
- Thermogenesis - WP4321 (Homo sapiens)
- Thiamine metabolic pathways - WP4297 (Homo sapiens)
- Threonine and methionine biosynthesis - WP423 (Saccharomyces cerevisiae)
- Threonine biosynthesis - WP331 (Saccharomyces cerevisiae)
- Toluene degradation - WP60 (Saccharomyces cerevisiae)
- Trans-sulfuration pathway - WP2333 (Homo sapiens)
- Trans-sulfuration pathway - WP3145 (Bos taurus)
- Trans-sulfuration, one-carbon metabolism and related pathways - WP2525 (Homo sapiens)
- Trehalose anabolism - WP398 (Saccharomyces cerevisiae)
- Trehalose degradation, low osmolarity - WP70 (Saccharomyces cerevisiae)
- Triacylglyceride synthesis - WP1013 (Bos taurus)
- Triacylglyceride synthesis - WP212 (Caenorhabditis elegans)
- Triacylglyceride synthesis - WP325 (Homo sapiens)
- Triacylglyceride synthesis - WP386 (Mus musculus)
- Triacylglyceride synthesis - WP782 (Gallus gallus)
- Triacylglycerol biosynthesis - WP627 (Arabidopsis thaliana)
- Triglyceride biosynthesis - WP266 (Saccharomyces cerevisiae)
- Tryptophan biosynthesis - WP165 (Saccharomyces cerevisiae)
- Tryptophan catabolism leading to NAD+ production - WP4210 (Homo sapiens)
- Tryptophan degradation - WP301 (Saccharomyces cerevisiae)
- Tryptophan degradation via kynurenine - WP452 (Saccharomyces cerevisiae)
- Tryptophan metabolism - WP1126 (Canis familiaris)
- Tryptophan metabolism - WP270 (Rattus norvegicus)
- Tryptophan metabolism - WP3248 (Bos taurus)
- Tryptophan metabolism - WP465 (Homo sapiens)
- Tryptophan metabolism - WP79 (Mus musculus)
- Turbo design of glycolysis - WP3636 (Saccharomyces cerevisiae)
- Tyrosine biosynthesis - WP538 (Saccharomyces cerevisiae)
- Tyrosine metabolism and related disorders - WP4506 (Homo sapiens)
- UDP-L-arabinose biosynthesis I from UDP-xylose - WP3015 (Arabidopsis thaliana)
- UDP-derived sugars synthesis in fibroblasts - WP5394 (Homo sapiens)
- UDP-glucose conversion - WP109 (Saccharomyces cerevisiae)
- Upiquinone Q prenylation - WP287 (Saccharomyces cerevisiae)
- Urea cycle and associated pathways - WP4595 (Homo sapiens)
- Urea cycle and metabolism of amino groups - WP3245 (Bos taurus)
- Urea cycle and metabolism of amino groups - WP497 (Homo sapiens)
- Urea cycle and related diseases - WP4571 (Homo sapiens)
- Ureide biosynthesis - WP617 (Oryza sativa)
- Valine biosynthesis - WP2 (Saccharomyces cerevisiae)
- Valine, leucine and isoleucine degradation - WP1451 (Caenorhabditis elegans)
- Valproic acid pathway - WP3871 (Homo sapiens)
- Vanillin and isovanillin metabolism - WP4501 (Rattus norvegicus)
- Vitamin A and carotenoid metabolism - WP716 (Homo sapiens)
- Vitamin A1 and A5/X pathways - WP5397 (Homo sapiens)
- Vitamin B12 disorders - WP4271 (Homo sapiens)
- Vitamin B12 metabolism - WP1533 (Homo sapiens)
- Vitamin B12 metabolism - WP3193 (Bos taurus)
- Vitamin B6-dependent and responsive disorders - WP4228 (Homo sapiens)
- Vitamin D in inflammatory diseases - WP4482 (Homo sapiens)
- Vitamin D metabolism - WP1531 (Homo sapiens)
- Vitamin D metabolism - WP3162 (Bos taurus)
- Vitamin K metabolism and activation of dependent proteins - WP5186 (Homo sapiens)
- Vitamins A and D - action mechanisms - WP4342 (Homo sapiens)
- Warburg effect modulated by deubiquitinating enzymes and their substrates - WP5216 (Homo sapiens)
- Xylulose-monophosphate cycle - WP361 (Saccharomyces cerevisiae)
- mRNA, protein, and metabolite inducation pathway by cyclosporin A - WP3953 (Homo sapiens)
- miRNA biogenesis - WP2338 (Homo sapiens)